Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in

  News Archive

New Vaccine For Chlamydia to Use Synthetic Biology
Tuesday, August 04, 2015
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.

Researchers Discover Immune System’s 'Trojan Horse'
Monday, August 03, 2015
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.

How to Become a Follicular T Helper Cell
Monday, August 03, 2015
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.

First Artificial Ribosome Designed
Friday, July 31, 2015
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.

Retrogenix Co-founders Attend Reception at Buckingham Palace
Friday, July 31, 2015
HM the Queen welcomes winners of the 2015 Queen's Award for Enterprise.

Malvern Instruments Establishes New Biopharmaceutical Applications Laboratory
Friday, July 31, 2015
Malvern Instruments has established a new biopharmaceutical applications laboratory in the heart of San Diego’s biotechnology cluster.

Experimental MERS Vaccine Shows Promise in Animal Studies
Thursday, July 30, 2015
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.

New Consortium to Develop and Study Early Stage Drugs
Thursday, July 30, 2015
An innovative new Consortium will act as a ‘match-making’ service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.

Firms “Under-invest” in Long-Term Cancer Research
Thursday, July 30, 2015
Tweaks to the R&D pipeline could create new drugs and greater social benefit.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 1441

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos